Dalcetrapib (JTT-705)

211513-37-0

RO4607381

C08845-5mg

CETP

Metabolism

CCC (CC) CC1 (CCCCC1) C (=O) NC2=CC=CC=C2SC (=O) C (C) C

C23H35NO2S

Dalcetrapib (JTT-705) is a rhCETP inhibitor with IC50 of 0.2 μM that increases the plasma HDL cholesterol. Phase 3.

2 years -80 in solvent

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

RC202167L3 10 µg

Ask

AMM13959V 100 µL

Ask

abx976248-01 150 µg

Ask

abx976248-02 300 µg

Ask

R34089-100UG 100 µg

Ask

MF-0080217-01 50 µL

Ask